James Karis

KMR Group, Inc. provides benchmarking, analytics and performance management services. It offers data, products, and services in the form of reports and on-line tools that inform client strategy and productivity as well as day-to-day operations, including portfolio optimization, site selection, and enrollment management. The company was founded by Linda Martin and James M. Karis in 1991 and is headquartered in Chicago, IL.

Pharmaco International Ltd. manufactures veterinary and human drugs and toiletries. The company is headquartered in Dhaka, Bangladesh.

Saama Technologies, Inc. engages in the provision of consulting and systems integration services. It offers study conduct, study planning, and real world and commercial insight solutions The company was founded by Suresh Katta in 1997 and is headquartered in Campbell, CA.

MAPI Développement SAS engages in conceiving and implementing studies to evaluate drugs. It provides research and clinical trial services, risk management plan, direct patient management, signal detection, strategic consulting and linguistic validation. The company was founded by Bernard Jambon in 1974 and is headquartered in Lyon, France.

CollabRx uses information technology to inform personalized cancer treatment planning by combining the world's knowledge on cutting-edge therapies with specific insights from the nation's top cancer experts starting with the area of greatest need advanced cancers in patients who have effectively exhausted the standard of care. For physicians, Collabrx provides sophisticated, yet intuitive decision support tools to help them rapidly and accurately determine which medical tests, therapies, and clinical trials should be considered in order to deliver the best possible care to their patients. For patients, CollabRx provides actionable and highly-credible information that can be shared with their oncologist in a form that supports collaborative decision making in determining a cancer treatment plan that is customized for them. For researchers, CollabRx provides a framework to categorize the molecular subtypes of cancer based on the genetic profile of the tumor, and more importantly link specific subtypes to relevant treatments and ultimately patient clinical outcomes to drive the science and medicine forward.

CollabRx, Inc. is a data analytics company. It offers cloud-based systems, which provides clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision-making. Its CollabRx Therapy Finders product provides information to physicians and patients for rapidly determining which medical tests, therapies, and clinical trials may be considered in cancer treatment planning with a specific emphasis on the tumor genetic profile. The company was founded by Jeff Shrager in December 1989 and is headquartered in San Francisco, CA.

Mapi Group provides healthcare services. The private company is based in Lyon, France. The CEO of the French company is James M. Karis.